3-phenyl-5-(thiophen-3-yl)-1,2,4-oxadiazole | 255866-91-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-phenyl-5-(thiophen-3-yl)-1,2,4-oxadiazole
• 英文别名: 3-Phenyl-5-(thiophen-3-yl)-[1,2,4]oxadiazole；3-phenyl-5-thiophen-3-yl-1,2,4-oxadiazole
• CAS: 255866-91-2
• 化学式: C₁₂H₈N₂OS
• mdl: MFCD00109279
• 分子量: 228.274
• InChiKey: PKWFNMPFPRRZTB-UHFFFAOYSA-N

物化性质

• 沸点：
  392.2±44.0 °C(Predicted)
• 密度：
  1.277±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  67.2
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  苯甲酰胺肟 在 N,N'-羰基二咪唑 、 sodium hydroxide 作用下， 以 二甲基亚砜 为溶剂， 反应 20.5h， 生成 3-phenyl-5-(thiophen-3-yl)-1,2,4-oxadiazole
  参考文献：
  名称：

  容易从室温获得的1,2,4-恶二唑核的组装，该酰胺由现成的a胺肟和羧酸制成

  摘要：

  报道了在超碱促进条件下从a胺肟和羧酸合成3,5-二取代-1,2,4-恶二唑的一锅法环境温度程序。

  DOI：

  10.1016/j.tetlet.2018.06.019

文献信息

• A facile approach to synthesize 3,5-disubstituted-1,2,4-oxadiazoles via copper-catalyzed-cascade annulation of amidines and methylarenes
  作者：Wei Guo、Kunbo Huang、Fanghua Ji、Wanqing Wu、Huanfeng Jiang

  DOI：10.1039/c5cc02110c

  日期：——

  Various 3,5-disubstituted-1,2,4-oxadiazoles are smoothly formed via copper-catalyzed cascade annulation of amidines and methylarenes. This tandem oxidation-amination-cyclization transformation represents a straightforward protocol to prepare 1,2,4-oxadiazoles from easily available starting materials, with...

  各种3,5-二取代-1,2,4-恶二唑是通过铜催化的am和甲基芳烃的级联环化反应顺利形成的。这种串联的氧化-胺化-环化反应代表了一种简单的方法，可以从容易获得的起始原料中制备1,2,4-恶二唑，并采用...
• A novel synthesis of 1,2,4-oxadiazoles and isoxazoles
  作者：Arif Kivrak、Metin Zora

  DOI：10.1016/j.tet.2013.12.043

  日期：2014.1

  A novel synthesis of 1,2,4-oxadiazoles and isoxazoles is described by utilizing the reactions between amidoximes and α,β-alkynic aldehydes and/or ketones. Conjugate addition products, obtained from amidoximes and α,β-alkynic aldehydes and/or ketones, afford 1,2,4-oxadiazoles and isoxazoles when treated with bases and acids, respectively. 1,2,4-Oxadiazoles can also be synthesized directly from amidoximes

  通过利用a肟和α，β-炔醛和/或酮之间的反应，描述了1,2,4-恶二唑和异恶唑的新型合成方法。从a胺肟和α，β-炔醛和/或酮获得的共轭加成产物在分别用碱和酸处理时分别得到1,2,4-恶二唑和异恶唑。1,2,4-氧杂二唑也可以在碱性条件下一锅法直接由a胺肟和α，β-炔醛合成。该反应对于各种起始化合物是通用的，并且可以耐受芳基，杂芳基和烷基的存在。
• METHOD FOR PRODUCING 1,2,4-OXADIAZOLE DERIVATIVE
  申请人：ASAHI GLASS COMPANY, LIMITED

  公开号：US20180037578A1

  公开（公告）日：2018-02-08

  The invention provides a production method of a 1,2,4-oxadiazole derivative represented by formula (A), which comprises reacting a compound represented by formula (B) and a compound represented by formula (C) in the presence of a basic compound: wherein Ar is an aromatic group or an aromatic group having substituent(s); W, X, Y and Z are each independently —S—, —N═, —CH═ or —CR═, and one selected from W, X, Y and Z is —S—; and R is an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, a haloalkyl group having 1 to 3 carbon atoms, a haloalkoxy group having 1 to 3 carbon atoms or a halogen atom.

  该发明提供了一种1,2,4-噁二唑衍生物的生产方法，其代表式为(A)，包括在碱性化合物存在下，将代表式为(B)的化合物与代表式为(C)的化合物反应：其中Ar是芳香基团或具有取代基的芳香基团；W、X、Y和Z各自独立地为—S—、—N═、—CH═或—CR═，其中W、X、Y和Z中选定的一个是—S—；R是具有1至5个碳原子的烷基基团，具有1至3个碳原子的烷氧基团，具有1至3个碳原子的卤代烷基基团，具有1至3个碳原子的卤代烷氧基团或卤素原子。
• Novel oxadiazole derivatives and their medical use
  申请人：Dahl Bjarne H.

  公开号：US20090312347A1

  公开（公告）日：2009-12-17

  This invention relates to novel oxadiazole derivatives, which are found to be modulators of the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

  本发明涉及一种新型的噁唑烷衍生物，其被发现是尼古丁乙酰胆碱受体的调节剂。由于其药理学特性，本发明中的化合物可能对治疗与中枢神经系统（CNS）的胆碱能系统、外周神经系统（PNS）、平滑肌收缩相关的疾病或疾患、内分泌疾病或疾患、神经退行性疾病或疾患、炎症、疼痛以及由于滥用化学物质而引起的戒断症状等疾病或疾患具有用处。
• NOVEL OXADIAZOLE DERIVATIVES AND THEIR MEDICAL USE
  申请人：DAHL Bjarne H.

  公开号：US20110294856A1

  公开（公告）日：2011-12-01

  This invention relates to novel oxadiazole derivatives, which are found to be modulators of the nicotinic acetylcholine receptors. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

  本发明涉及一种新型的噁唑啉衍生物，其被发现是乙酰胆碱受体的调节剂。由于它们的药理特性，该发明中的化合物可能有用于治疗各种与中枢神经系统（CNS）的胆碱能系统、外周神经系统（PNS）、平滑肌收缩、内分泌疾病或紊乱、神经退行性疾病、炎症、疼痛以及由于滥用化学物质终止而引起的戒断症状相关的疾病或紊乱。